Oral iron supplementation after blood donation: A randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 313, Issue 6, 2015, Pages 575-583

  Kiss, Joseph E ^a   Brambilla, Donald ^b   Glynn, Simone A ^c   Mast, Alan E ^d   Spencer, Bryan R ^e   Stone, Mars ^f   Kleinman, Steven H ^g   Cable, Ritchard G ^e  

^a INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

^b RTI INTERNATIONAL   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d BLOOD RESEARCH INSTITUTE   (United States)

^e AMERICAN RED CROSS   (United States)

^f BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FERROUS GLUCONATE; HEMOGLOBIN; IRON; TRANSFERRIN RECEPTOR; FERROUS ION;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; DRUG MEGADOSE; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEPLETION; IRON STORAGE; LABORATORY TEST; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; TABLET FORMULATION; UNITED STATES; BLOOD; CLINICAL TRIAL; DIET SUPPLEMENTATION; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; BLOOD CELL COUNT; BLOOD DONORS; DIETARY SUPPLEMENTS; FEMALE; FERRITINS; FERROUS COMPOUNDS; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED;

EID: 84922559695     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.119     Document Type: Article

References (24)

1. Baart AM, van Noord PAH, Vergouwe Y, et al. High prevalence of subclinical iron deficiency in whole blood donors not deferred for low hemoglobin. Transfusion. 2013;53(8):1670-1677.
2. Cable RG, Glynn SA, Kiss JE, et al; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2012;52(4):702-711.
3. Whitaker BI, Hinkins S. 2011 National blood collection and utilization survey report. US Dept of Health and Human Services. http://www.hhs.gov/ash/bloodsafety/2011-nbcus.pdf. Accessed November 25, 2014.
4. Krayenbuehl PA, Battegay E, Breymann C, Furrer J, Schulthess G. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. 2011; 118(12):3222-3227.
5. Brownlie T IV, Utermohlen V, Hinton PS, Haas JD. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr. 2004;79(3):437-443.
6. Murray-Kolb LE, Beard JL. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr. 2007;85(3):778-787.
7. Falkingham M, Abdelhamid A, Curtis P, Fairweather-Tait S, Dye L, Hooper L. The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis. Nutr J. 2010;9:4.
8. Bryant BJ, Yau YY, Arceo SM, Hopkins JA, Leitman SF. Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome. Transfusion. 2013;53(8):1637-1644.
9. Spencer BR, Kleinman S, Wright DJ, et al; REDS-II RISE Analysis Group. Restless legs syndrome, pica, and iron status in blood donors. Transfusion. 2013;53(8):1645-1652.
10. Blood Products Advisory Committee meeting: July 27, 2010. US Food and Drug Administration. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/ucm221857.htm. Accessed December 22, 2014.
11. Smith GA, Fisher SA, Doree C, Di Angelantonio E, Roberts DJ. Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors. Cochrane Database Syst Rev. 2014;7:CD009532.
12. Cable RG, Glynn SA, Kiss JE, et al; NHLBI Retrovirus Epidemiology Donor Study-II. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2011;51(3):511-522.
13. Kiss JE, SteeleWR, Wright DJ, et al; NHLBI Retrovirus Epidemiology Donor Study-II. Laboratory variables for assessing iron deficiency in REDS-II Iron Status Evaluation (RISE) blood donors. Transfusion. 2013;53(11):2766-2775.
14. Pottgiesser T, SpeckerW, Umhau M, Dickhuth HH, Roecker K, Schumacher YO. Recovery of hemoglobinmass after blood donation. Transfusion. 2008;48(7):1390-1397.
15. Punnonen K, Irjala K, Rajamäki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89(3): 1052-1057.
16. Mast AE, Schlumpf KS, Wright DJ, et al; NHLBI Retrovirus Epidemiology Donor Study-II. Demographic correlates of low hemoglobin deferral among prospectivewhole blood donors. Transfusion. 2010;50(8):1794-1802.
17. Simon TL, Garry PJ, Hooper EM. Iron stores in blood donors. JAMA. 1981;245(20):2038-2043.
18. Radtke H, Tegtmeier J, Röcker L, Salama A, Kiesewetter H. Daily doses of 20mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study. Transfusion. 2004;44 (10):1427-1432.
19. Wadsworth GR. Recovery from acute haemorrhage in normal men and women. J Physiol. 1955;129(3):583-593.
20. Fowler WM, Barer AP. Rate of hemoglobin regeneration in blood donors. JAMA. 1942;118(6): 421-427.
21. Dot D, Miró J, Fuentes-Arderiu X. Within-subject biological variation of hematological quantities and analytical goals. Arch Pathol Lab Med. 1992;116(8): 825-826.
22. Cable RG, SteeleWR, Melmed RS, et al; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). The difference between fingerstick and venous hemoglobin and hematocrit varies by sex and iron stores. Transfusion. 2012;52(5):1031-1040.
23. Karp JK, King KE. International variation in volunteer whole blood donor eligibility criteria. Transfusion. 2010;50(2):507-513.
24. Eder A. Proposed changes to hemoglobin and donation interval criteria for whole blood donors: projected impact on current donor base. Paper presented at: 98th meeting of Blood Products Advisory Committee, US Food and Drug Administration; July 28, 2008; Gaithersburg, MD. http://www.fda.gov/ohrms/dockets/ac/cber08.html#BloodProducts. Accessed November 14, 2014.